Form D Explorer
X4 Pharmaceuticals, Inc · CIK 1501697

Report a data issueCitable research briefCompare issuerPrivate research collection

X4 Pharmaceuticals, Inc

CIK 1501697 · Corporation · Inc. DELAWARE · BOSTON, Massachusetts · Biotechnology

These Form D notices describe private placements reported to the SEC. Read Form D/A amendments alongside the original disclosures.

Filings
1
Original notices
1
Amendments
0
Activity
Aug 25, 2025
through Aug 25, 2025

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Choose filings to compare · Research this issuer step by step

Latest available filing snapshot: how to read these fields

Form D · Aug 25, 2025

Reported offering amount
$84,999,985
Reported exemptions
Rule 506(b)
Reported amount sold
$84,999,985

This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.

Form D filings (1)